As lung cancer treatments evolve and more data are published, there is a need for updated recommendations on how to manage ...

Dr. Singhi speaks with us about the importance of biomarker testing and what you need to know to get the best lung cancer ...

Dr. Jacob A. Sands shares how patients with lung cancer can interpret clinical trial results and how these findings translate ...

Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S.

Researchers at Detroit-based Karmanos Cancer Institute are harnessing robotic technology to accelerate the search for more effective pancreatic ...

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...

Since the development of crizotinib (Xalkori), oncologists can now choose from an array of later-generation drugs in the ...

Dr. Anshul clarifies that while early breast cancer improves survival rates, recurrence risk remains high, especially in ...

When you're facing metastatic breast cancer, the questions can pile up fast. Here are some clear answers to guide you.

Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.

Kelly Paulson, MD, PhD: ES-SCLC is, of course, a very aggressive form of lung cancer that affects about 35,000 Americans each. Most SCLC presents in the metastatic setting or extensive stage, and ...

Genmab acquires Merus for $8B, boosting cancer drug pipeline with petosemtamab. Check out what this deal means for GMAB and ...